PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma

FDA inspection history in Greenville, South Carolina, 2015 to 2023

3
Form 483s

Every document, by year

  • Form 483

2015: one Form 483; 2019: one Form 483; 2023: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2015One Form 483, at Greenville, South Carolina.
  2. 2019One Form 483, at Greenville, South Carolina.
  3. 2019The longest 483 on file: 4 observations over 5 pages at Greenville, South Carolina.
  4. 2023One Form 483, at Greenville, South Carolina.

Cited most

Across all PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma observations on file

The complete PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Documents

3 on file, newest first
DateDocumentPrice
2023-08-02483 Form 483$99
2019-02-22483 Form 483$99
2015-08-20483 Form 483$99

Investigators on these documents

Bonita S. Chester (1)Joseph F. Owens (1)

FEI number 1017687 · most recent document Aug 2, 2023

About PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma

How many FDA Form 483s has PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma received?

FDA Intel has 3 Form 483s on file for PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma; the most recent is dated Aug 2, 2023.

When was PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma last inspected by FDA?

The most recent FDA inspection document on file for PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma is a Form 483 dated Aug 2, 2023, for the site in Greenville, South Carolina.

What did FDA cite at PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma?

The regulations cited most in the observations on file for PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma are 21 CFR 314.80(b) (Postmarketing reporting of adverse drug experiences), 2 times; 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.188 (Batch production and control records), 1 time.